Key result
AMP-activated protein kinase is a major regulator of cardiac energy metabolism, essential for adaptation to acute stress but potentially maladaptive in chronic cardiovascular diseases.
This review highlights the dual role of AMPK in the heart, acting as a crucial adaptive mechanism during acute stress while potentially contributing to maladaptive processes in chronic cardiovascular diseases.
Requires caution in chronic AMPK targeting for CVD; leaves open optimal therapeutic windows.
The heart is capable of utilizing a variety of substrates to produce the necessary ATP for cardiac function. AMP-activated protein kinase (AMPK) has emerged as a key regulator of cellular energy homeostasis and coordinates multiple catabolic and anabolic pathways in the heart. During times of acute metabolic stresses, cardiac AMPK activation seems to be primarily involved in increasing energy-generating pathways to maintain or restore intracellular ATP levels. In acute situations such as mild ischemia or short durations of severe ischemia, activation of cardiac AMPK appears to be necessary for cardiac myocyte function and survival by stimulating ATP generation via increased glycolysis and accelerated fatty acid oxidation. Whereas AMPK activation may be essential for adaptation of cardiac energy metabolism to acute and/or minor metabolic stresses, it is unknown whether AMPK activation becomes maladaptive in certain chronic disease states and/or extreme energetic stresses. However, alterations in cardiac AMPK activity are associated with a number of cardiovascular-related diseases such as pathological cardiac hypertrophy, myocardial ischemia, glycogen storage cardiomyopathy, and Wolff-Parkinson-White syndrome, suggesting the possibility of a maladaptive role. Although the precise role AMPK plays in the diseased heart is still in question, it is clear that AMPK is a major regulator of cardiac energy metabolism. The consequences of alterations in AMPK activity and subsequent cardiac energy metabolism in the healthy and the diseased heart will be discussed.
No takes yet. Share an insight, caveat, or question.
Dolinsky et al. (2006) conducted a review in Cardiovascular diseases. AMP-activated protein kinase (AMPK) activity was evaluated. AMP-activated protein kinase is a major regulator of cardiac energy metabolism, essential for adaptation to acute stress but potentially maladaptive in chronic cardiovascular diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: